Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Last trade$0.82
Day change-$0.0409 (-4.75%)
Day range$0.81 – $0.885
Volume66,861
Market cap$45M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$44.68M
Price / earnings
—
Price / book
4.17×
Price / sales
—
EV / sales
—
EV / EBITDA
-2.2×
Profitability
Earnings per share
-$0.28
Return on assets
-62.18%
Return on equity
-136.84%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
1.41×
Quick ratio
1.41×
Cash ratio
1.02×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$12.79M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TLPH, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$0
$0
$0
$0
$1K
$0
$27K
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$1K
$0
$27K
$0
Selling, general and administrative
$1.95M
$2.23M
$2.3M
$1.89M
$1.62M
$2.19M
$1.77M
$1.67M
Research and development
$2.19M
$1.69M
$1.65M
$1.56M
$1.8M
$1.5M
$1.17M
$1.32M
Total operating expenses
$4.14M
$3.92M
$3.95M
$3.45M
$3.42M
$3.69M
$2.94M
$3M
Operating income
-$4.14M
-$3.92M
-$3.95M
-$3.45M
-$3.42M
-$3.69M
-$2.92M
-$3M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$4.02M
-$4.31M
-$2.56M
-$3.77M
-$4.44M
-$3.49M
-$2.67M
-$2.26M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$4.02M
-$4.31M
-$2.56M
-$3.77M
-$4.44M
-$3.49M
-$2.59M
-$2.26M
Net income attributable to common shareholders
-$4.02M
-$4.31M
-$2.56M
-$3.77M
-$4.44M
-$3.49M
-$2.59M
-$1.87M
EBITDA
-$4.14M
-$3.92M
-$3.95M
-$3.45M
-$3.42M
-$3.69M
-$2.92M
-$3M
Basic earnings per share
-$0.05
-$0.06
-$0.04
-$0.06
-$0.11
-$0.10
-$0.10
-$0.07
Diluted earnings per share
-$0.05
-$0.06
-$0.04
-$0.06
-$0.11
-$0.10
-$0.10
-$0.07
Recent news
Company coverage with links to the original publishers.
ALPHEA, a platform building infrastructure for AI agents, has secured $5 million in strategic funding from investors including MH Ventures, IBC Ventures, Titan Ventures, and Becker Ventures. The funding will accelerate product development and expand ALPHEA's global node ecosystem, enabling AI agents to run, collaborate, store data, and settle value efficiently in a distributed cloud environment designed specifically for autonomous AI operations.
ALPHEA, an AI infrastructure platform, has raised $5 million in strategic funding from investors including MH Ventures, IBC Ventures, Titan Ventures, and Becker Ventures. The funding will accelerate development of ALPHEA's AI-native distributed cloud designed specifically for autonomous agents, with plans to expand its global node ecosystem and improve developer tools.
Shares of Sintx Technologies, Inc. (NASDAQ: SINT) rose sharply in today’s pre-market trading after the company announced its subsidiary Technology Assessment & Transfer entered into a Cooperative Research and Development agreement with the U.S. Army Combat Capabilities Development Command Army Research Laboratory.
Sintx Technologies shares jumped 39.3% to $0.3393 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) gained 50.3% to $11.95 in pre-market trading after dipping around 39% on Tuesday.
Minim, Inc. (NASDAQ: MINM) shares jumped 31.1% to $3.33 in pre-market trading. David E. Lazar disclosed a 51% active stake in Minim Inc.
Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) surged 25.5% to $0.1010 in pre-market trading after falling around 7% on Tuesday.
Paramount Global (NASDAQ: PARA) gained 20.6% to $16.50 in pre-market trading. Byron Allen offered $14.3 billion to buy all of the outstanding shares of Paramount Global, Bloomberg reported.
Pop Culture Group Co., Ltd (NASDAQ:
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.